Terrence Higgins Trust chief executive Rosemary Gillespie steps down

Illustrated rainbow pride flag on a white background.

The chief executive of leading HIV charity the Terrence Higgins Trust, Rosemary Gillespie, has stepped down.

In a statement sent to PinkNews today, the board of THT asked Dr Gillespie to step down with immediate effect.

The board noted “a change of leadership is needed for the next stage of the organisation’s development.”

Dr Gillespie was congratulated by the board for her work at THT since her appointment last January.

Robert Glick, Chair of the Board of Trustees, said: “On behalf of the entire Board, it has been a privilege to work with Rosemary as she has led this remarkable charity over the last 15 months, during a period marked by considerable change.  She has been the driving force in developing a new strategy for THT, in making certain we have a solid organisational and financial footing for a more sustainable future, and in helping to guide the vital work we do each and every day.

“Each of us can be proud of what THT has accomplished under Rosemary’s stewardship, on behalf of the tens of thousands of people we serve – providing the information, advice, counselling, testing and support to those often in desperate need. She leaves THT well-positioned to become an even more effective organisation, poised to deliver on our dual ambition of stopping HIV transmission in our lifetime and in ensuring that people living with HIV can pursue healthy lives, free from prejudice and from discrimination.

“One of Rosemary’s most lasting legacies will be the exceptionally gifted and skilled team of executives she has recruited and managed, who together lead our talented and dedicated staff. The Board remains grateful to her for managing that outstanding team who has come together to work relentlessly for a common goal.

“The Board is committed to ensuring a smooth transition, and to that effect will be communicating shortly its plans for interim arrangements, and then the recruitment of a permanent Chief Executive.”

Dr Gillespie’s replacement has not been announced.